Prescription price transparency is critical to lowering patients’ out-of-pocket costs and preventing “sticker shock” at the pharmacy, which negatively impacts medication adherence and patient safety.

September 17, 2018

Actionable Intelligence at the Point of Care can Help Prevent Physician Burnout

It’s no secret that today’s physicians are expected to do more with less—less than complete patient information, less time to spend with each patient, fewer resources in general—all while delivering high-quality, cost-effective care to an increasingly value-focused and highly regulated consumer marketplace. The stakes are high, and many of these factors can lead to burnout. Read more...

September 07, 2018

Surescripts Tackles Prescription Abandonment with Point-of-Care Information That Supports Patient-Provider Shared Decision Making

Surescripts was recently recognized with Frost & Sullivan’s Best Practices Award for New Product Innovation. Below is a blog post from guest contributor Nancy Fabozzi, Principal Analyst for Digital Health with Frost & Sullivan. Read more...

August 28, 2018

Five Questions: Mary Ann Chaffee on Price Transparency, Public Health and the Notorious R.B.G.

As Vice President for Policy and Federal Affairs, Mary Ann Chaffee leads Surescripts efforts to help inform federal healthcare policy. [...] [Melissa Nix, Editorial Director] recently sat down with Mary Ann to talk about the healthcare hot topic that’s giving the buzz over interoperability a run for its money: price transparency.  Read more...

August 01, 2018

Patients, Pocketbooks and a Podcast on Prescription Price Transparency

The need for greater price transparency in healthcare is all over the news. Policy makers across the country have taken up the cause. Patients are demanding real change, as healthcare costs continue to rise and hit pocketbooks hard.  Read more...

April 23, 2018

Patients’ Out-of-Pocket Cost Should Weigh Into Prescribing Decisions

Americans spent $425 billion on prescriptions in 2015, a more than 12 percent increase from 2014. And the nation’s spending on medicines is forecasted to reach $610-640 billion in 2020. Adding to these costs is prescription abandonment due to unpleasant copay surprises at the pharmacy and the resulting medication non-adherence.  Read more...

March 22, 2018

HIMSS18 Panel Gets Candid About Prescription Price Transparency

In advance of its highly anticipated conference—widely regarded as the world’s largest health information tradeshow—HIMSS posed this question on its homepage: “Are you ready for the next step in health?” Based on the enthusiasm of the more than 40,000 people who traveled to Las Vegas for this year’s show, the answer was a resounding “yes!” Read more...